The UK multiple sclerosis (MS) market is highly competitive with a dynamic pipeline. It’s moving into an exciting and challenging period with a number of key players and products emerging, along with game changers for primary progressive MS, which was a previously underserved population, along with secondary progressive MS.
This brings about a number of challenges for both the current players and also new treatments launching into this evolving therapy area.
Experienced Consultants in Multiple Sclerosis
Our Therapy Area Team will work closely with you to help identify the most suitable approach, challenge when necessary and provide actionable insights to help navigate your marketing challenges. We have dedicated Senior Consultants and Therapy Area Teams that keep abreast of the full market landscape.
Adelphi MarketMapsTM have been developed to summarise and visualise the full market landscape including the key challengers, market trends and the likely impact of pipeline treatments.
The Types of Challenges we Help to Solve
- Patient support programme evaluation research
- Investigating MS forecasting
- Understanding funding & value in MS with payers
- Understanding the patient journey and experiences
- Campaign development and testing, ensuring campaigns reflect reality